We have developed a model in which inflammation contiguous to and within a dorsal root ganglion (DRG) was generated by local application of complete Freund's adjuvant (CFA) to the L4 lumbar spinal nerve as it exits from the intervertebral foramen. The periganglionic inflammation (PGI) elicited a marked reduction in withdrawal threshold to mechanical stimuli and an increase in heat pain sensitivity in the ipsilateral hindpaw in the absence of any hindpaw inflammation. The pain sensitivity appeared within hours and lasted for a week. The PGI also induced a prominent increase in IL-1b and TNF-a levels in the DRG and of cyclooxygenase-2 (COX-2) expression in neurons and satellite cells. A selective COX-2 inhibitor reduced the PGI-induced hyperalgesia. We also show that IL-1b induces COX-2 expression and prostaglandin release in DRG neurons in vitro in a MAP kinase-dependent fashion. The COX-2 induction was prevented by ERK and p38 inhibitors. We conclude that periganglionic inflammation increases cytokine levels, including IL-1b, leading to the transcription of COX-2 and prostaglandin production in the affected DRG, and thereby to the development of a dermatomally distributed pain hypersensitivity. Ó
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Introduction
Although acute low back pain (LBP) is amongst the most common of medical complaints [3] the pathophysiology of the pain is poorly understood. Acute low back pain may result from mechanical compression of spinal roots and the dorsal root ganglion [8, 59] , arthritis of intervertebral articular joints and damage or inflammation of paravertebral muscles and tendons [34] . Although intervertebral disc herniation is considered to produce pain primarily by mechanical compression of spinal roots [8] , recent data also suggest a role for local inflammation [42] . High levels of IL-1a, IL-1b, IL-6 and TNF-a are present in herniated lumbar discs [53] . Pain radiating from the back down the leg to the foot is a characteristic symptom of lumbar radiculopathy, is present in 25-57% of LBP cases [48] and correlates with the severity of the disease [50] . Radiculopathy may not always be accompanied by clearly defined nerve root compression or sensory or motor deficits [42] , implying that other factors, such as inflammation, may contribute in some patients, particularly in the acute phase. However, it is uncertain whether inflammation of the dorsal root or DRG without compression can by itself induce pain hypersensitivity. This is what we have now investigated.
Prostaglandin E2 (PGE2), a major pain enhancing inflammatory mediator [47] , is produced from arachidonic acid by a sequence of enzymes that include cyclooxygenase (COX). Tissue damage and inflammation result in a strong local induction of COX-2, the inducible isoform of COX [57] . In addition, peripheral inflammation induces via a central action of IL-1b, COX-2 in spinal cord dorsal horn neurons [23, 46, 54, 61] . Although DRG neurons are capable of expressing COX-2 in response to direct cytokine application in vitro [16] , neither peripheral nerve injury nor distal peripheral inflammation induce COX-2 in the DRG in vivo [6] . Nevertheless, since NSAIDs [56] and COX-2 selective inhibitors [28, 43] reduce pain in some patients with acute LBP, a COX dependent prostaglandin synthesis is likely in some way and at some location, to contribute to the pain hypersensitivity.
Peripheral inflammation induces a local inflammatory hyperalgesia that is due both to the sensitization of nociceptor peripheral terminals at the site of the inflammation (peripheral sensitization) [27] and of dorsal horn neurons (central sensitization) [60] , both of which involve COX-2 induction, the former locally in immune cells [4, 49] and the latter in dorsal horn neurons [46] . When the sciatic nerve is treated locally at the mid thigh level with CFA [14] or zymosan [7] this also produces a sustained pain hypersensitivity in the hindpaw in the absence of inflammation in the paw. 
